Skip to content

Alterola Biotech, Inc.: 10-Q filed 2020-10-07

What Alterola Biotech, Inc. reported in its quarterly report filed 2020-10-07 (fiscal Q3 2018): 23 published measures, 63 facts as tagged in accession 0001663577-20-000363.

This filing

Form
10-Q (quarterly report)
Filed
2020-10-07
Fiscal period
fiscal Q3 2018
Accession
0001663577-20-000363 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Alterola Biotech, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-06-3077,742USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-06-3075,053USD
At 2017-09-30294,678USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-06-302,689USD
At 2017-09-30-294,678USD
At 2016-09-30-264,046USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-06-300USD
At 2017-09-300USD
At 2017-06-300USD
At 2016-09-300USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-10-01 to 2018-06-30207,367USD273
2016-10-01 to 2017-09-30-67,632USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-10-01 to 2018-06-30-19,950USD273
2016-10-01 to 2017-06-300USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2018-04-01 to 2018-06-300USD91
2017-10-01 to 2018-06-300USD273
2017-04-01 to 2017-06-300USD91
2016-10-01 to 2017-06-300USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-10-01 to 2018-06-3019,950USD273
2016-10-01 to 2017-06-300USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-06-30-372,141USD
At 2017-09-30-579,508USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-04-01 to 2018-06-3027,000USD91
2017-10-01 to 2018-06-3027,000USD273
2017-04-01 to 2017-06-300USD91
2016-10-01 to 2017-06-300USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-62,458USD91
2017-10-01 to 2018-06-30-64,963USD273
2017-04-01 to 2017-06-30-1,140USD91
2016-10-01 to 2017-06-30-3,416USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-06-3077,742USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2018-04-01 to 2018-06-30598USD91
2017-04-01 to 2017-06-304,625USD91

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-06-3055,103USD
At 2017-09-30294,678USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-04-01 to 2018-06-3062,458USD91
2017-10-01 to 2018-06-3064,963USD273
2017-04-01 to 2017-06-301,140USD91
2016-10-01 to 2017-06-303,416USD273

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-06-30258,850USD
At 2017-09-30169,850USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2018-06-3019,950USD
At 2017-09-300USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2018-06-3023,655USD
At 2017-09-3020,900USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-63,056USD91
2017-10-01 to 2018-06-30207,367USD273
2017-04-01 to 2017-06-30-5,765USD91
2016-10-01 to 2017-06-30-17,291USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-04-01 to 2018-06-300USD91
2017-10-01 to 2018-06-305USD273
2017-04-01 to 2017-06-30115USD91
2016-10-01 to 2017-06-30341USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-10-01 to 2018-06-300USD273
2016-10-01 to 2017-06-302,325USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2018-04-01 to 2018-06-30-598USD91
2017-10-01 to 2018-06-30272,330USD273
2017-04-01 to 2017-06-30-4,625USD91
2016-10-01 to 2017-06-30-13,875USD273

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2018-04-01 to 2018-06-300USD91
2017-10-01 to 2018-06-300USD273
2017-04-01 to 2017-06-300USD91
2016-10-01 to 2017-06-300USD273

Inspect the source

Entity
Alterola Biotech, Inc. / CIK 0001442999
Captured
2026-09-21T17:19:50.475Z
SEC response SHA-256
87a3a16f9156f52960516ff7604a147caa80abebfe964591df0bd913491df844

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001442999.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))